Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK778 in BK Nephropathy
NCT00104338Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of manitimus in BK virus nephropathy (BKVN), sponsored by Astellas Pharma. Started Jan 2005; status: terminated.
02
Drugs
manitimus
03
Conditions
BK virus nephropathy (BKVN)
Beyond the preview
Go deeper on NCT00104338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104338.